ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 221 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q1 2022. The put-call ratio across all filers is 1.42 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $308,971 | -15.8% | 56,692 | +3.7% | 0.00% | 0.0% |
| Q2 2023 | $366,876 | -22.8% | 54,676 | +1.6% | 0.00% | -33.3% |
| Q1 2023 | $475,142 | +17.9% | 53,810 | +2.0% | 0.00% | 0.0% |
| Q4 2022 | $402,926 | +6.9% | 52,739 | -0.4% | 0.00% | 0.0% |
| Q3 2022 | $377,000 | -10.7% | 52,930 | +1.4% | 0.00% | 0.0% |
| Q2 2022 | $422,000 | +1463.0% | 52,183 | +2555.6% | 0.00% | – |
| Q1 2022 | $27,000 | -50.9% | 1,965 | -0.1% | 0.00% | – |
| Q4 2021 | $55,000 | -20.3% | 1,967 | -3.4% | 0.00% | – |
| Q3 2021 | $69,000 | -23.3% | 2,036 | -7.3% | 0.00% | – |
| Q2 2021 | $90,000 | +30.4% | 2,197 | +28.6% | 0.00% | – |
| Q1 2021 | $69,000 | -38.9% | 1,709 | -10.7% | 0.00% | – |
| Q4 2020 | $113,000 | +16.5% | 1,914 | -4.0% | 0.00% | – |
| Q3 2020 | $97,000 | +3.2% | 1,994 | +2.5% | 0.00% | – |
| Q2 2020 | $94,000 | +141.0% | 1,946 | +39.8% | 0.00% | – |
| Q1 2020 | $39,000 | +290.0% | 1,392 | +300.0% | 0.00% | – |
| Q4 2019 | $10,000 | -9.1% | 348 | -3.9% | 0.00% | – |
| Q3 2019 | $11,000 | – | 362 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 3,030,434 | $23,152,516 | 15.55% |
| BERYLSON CAPITAL PARTNERS, LLC | 289,726 | $2,213,507 | 6.45% |
| Matrix Capital Management Company, LP | 11,572,590 | $88,414,588 | 1.69% |
| Pier Capital, LLC | 1,012,401 | $7,734,744 | 1.27% |
| VIKING GLOBAL INVESTORS LP | 29,993,708 | $229,151,929 | 1.15% |
| Eagle Health Investments LP | 607,860 | $4,644,050 | 1.07% |
| Triatomic Management LP | 130,805 | $999,350 | 0.84% |
| Aristotle Atlantic Partners, LLC | 1,880,567 | $14,367,532 | 0.80% |
| Senator Investment Group LP | 1,000,000 | $7,640,000 | 0.69% |
| ARK Investment Management | 9,201,245 | $70,297,512 | 0.61% |